Synapse Open Synapse
Biology

RNAi drug specialist ADARx raises $446M IPO

BioPharma Dive · · 3 min read

ADARx is the only maker of RNA-based drugs to go public since 2024 and the first RNAi biotech to price an IPO in the U.S. in more than a decade.

Latest from BioPharma Dive